MPP at the World Cancer Congress 2022 #WCC2022
MPP participated in the World Cancer Congress 2022 that took took place 18-20 October 2022 at the CICG – The International Conference Center Geneva with over 1,700 registered participants from 120 countries.
On Tuesday 18 October 2022, our MPP Head of Strategy, Policy and Market Access, Esteban Burrone participated in a discussion on “Increasing Access to Quality Assured and Affordable Essential Medicines for Cancer Care in Low- and Middle-Income Countries – How Can We Make This Happen?”
Panelists:
Esteban Burrone • Medicines Patent Pool
Dr. Mary Flaviane Nyangasi • National Cancer Control Program, Kenya
Dr. Yehoda Martei • Abramson Cancer Center, University of Pennsylvania
Christpoher Lim • PAHO
Pat Garcia-Gonzalez • The Max Foundation
On Wednesday 19 October 2022, those in attendance had a chance to meet Giulia Segafredo, our NCDs Access Manager, as she discussed “What is Voluntary Licensing and Why Does it Matter to Access Cancer Medicines?”
